• Navigation

    • Home
    • About
    • Research
    • Dendritic Cell
    • Pipeline
    • News
    • Contact
  • About
  • Science
    • Research
    • Dendritic Cell
  • Pipeline
  • News
    • News
    • Press Releases
    • Presentations
    • Publications
  • Contact
Old Couple checking their tablet

News & Publications

In The News

Pharmaceutical Commerce – Pharma Pulse 6/3: Preparing for the Pharma C-Suite

June 3, 2025

CGTLive – The Potential to Apply Immunotherapy DOC1021 to a Broad Array of Tumor Types

June 2, 2025

Texas CEO Magazine – Texas Weekly Deal Highlights 6/1/25

June 1, 2025

CGTLive – Laura Aguilar MD, PhD, on Evaluating Immunotherapy DOC1021 for Glioblastoma

May 31, 2025

In the clinic for April 10, 2025

April 10, 2025

See All Articles

Press Releases

Diakonos Oncology Presents Promising Phase I Results of Dubodencel (DOC1021) at the ASCO 2025 Annual Meeting

June 2, 2025

Diakonos Oncology Closes $20M financing to accelerate Phase 2 Glioblastoma Clinical Development Program

May 30, 2025

Diakonos Oncology Presents Phase I Analysis of DOC1021 at the 2025 American Academy of Neurology Annual Meeting

April 9, 2025

Diakonos Oncology to Present at Biotech Showcase 2025

January 10, 2025

Diakonos Oncology Appoints Laura Aguilar, M.D., Ph.D. as Chief Medical Officer

November 18, 2024

See All Press Releases

Company Presentations

Diakonos Oncology Presents Promising Phase I Results of Dubodencel (DOC1021) at the ASCO 2025 Annual Meeting

June 2, 2025

Diakonos Oncology Presents Phase I Analysis of DOC1021 at the 2025 American Academy of Neurology Annual Meeting

April 9, 2025

2025 Spring Symposium hosted by the William T. Shearer Center for Human Immunobiology

March 7, 2025

6th Annual Glioblastoma Drug Development Summit

February 19, 2025

SNO 2024 Presentation: DOC1021 Cell-Based Vaccination as Adjuvant Therapy for Glioblastoma: Phase I Clinical Trial Analysis

November 22, 2024

See All Company Presentations

Publications

Science Translational Medicine: A Unique Subset of Cytotoxic Effector Memory T-cells Enhances CAR T-cell Function against Pancreatic Ductal Adenocarcinoma. Konduri V, Joseph S, Byrd TT, et al.

May 5, 2022

FASEB Journal: MHC class I and II peptide homology regulates the cellular immune response. FASEB. Halpert MM, Konduri V, Liang D, et al.

April 16, 2020

Cancer Gene Therapy: Dendritic cell vaccination plus low-dose Doxorubicin for the treatment of spontaneous canine hemangiosarcoma. Konduri V*, Halpert MM*, et al. Cancer Gene Therapy.

January 23, 2019

Frontiers in Immunology: AIMp1 Potentiates TH1 polarization and is critical for effective antitumor and antiviral immunity. Liang D, Tian L, You R, et al.

January 15, 2018

OncoImmunology: Chemo-immunotherapy mediates durable cure of orthotopic KrasG12D/p53-/- pancreatic ductal adenocarcinoma. Oncoimmunology. Konduri V, Li D, Halpert MM, et al.

July 22, 2016

See All Publications
Connect with us on social
Twitter LinkedIn

Serving the Patient,
not the Cancer.

    • About
    • Research
    • Dendritic Cell
    • Pipeline
    • News
    • Contact
Expanded Access Program

©2025 Diakonos Oncology Corporation